White matter disease can absolutely be hereditary, but the answer depends on which type of white matter disease you’re talking about. At one end of the spectrum sit rare single-gene disorders like CADASIL and the leukodystrophies, where a mutation inherited from one or both parents directly causes white matter destruction. At the other end, the common white matter changes that show up on brain scans in older adults are shaped by dozens or hundreds of genetic variants working alongside blood pressure, diabetes, and other vascular risks. Twin studies estimate that genetics accounts for roughly three-quarters of the variation in white matter lesion volume, a number that surprises most people who assume these changes are purely a consequence of aging and lifestyle.
Twin Studies and the Heritability of White Matter Lesions
The white spots that radiologists flag on MRI scans, formally called white matter hyperintensities, become increasingly common after middle age. For decades, they were treated as a routine byproduct of high blood pressure and aging blood vessels. Genetic research has complicated that picture. Twin and family studies consistently report that hereditary factors play a large role in determining who develops these lesions and how extensively they spread.1PubMed Central. The genetics of white matter lesions
A study that measured heritability across different brain regions found that the overall heritability for white matter hyperintensity volume was about 0.76, meaning genetics explained roughly three-quarters of the person-to-person variation. Deep white matter lesions had similarly high heritability at 0.77, while periventricular lesions came in at 0.64. Even the brain region with the lowest genetic influence, the cerebellum, still showed a heritability of 0.18.2PubMed. White Matter Hyperintensities Are Under Strong Genetic Influence Research on identical twins has reinforced this, finding that monozygotic twins have highly similar white matter hyperintensity burdens as well as similar vascular risk profiles, confirming a shared genetic foundation for both.3Neurobiology of Aging. White matter hyperintensities and vascular risk factors in monozygotic twins
These heritability numbers are high by the standards of complex brain traits. They don’t mean your white matter will look identical to your parents’ scans, because environmental factors still matter. But they do mean that the tendency to develop white matter changes runs strongly in families, even after accounting for shared habits and blood pressure levels.
Single-Gene Disorders That Directly Damage White Matter
Some white matter diseases follow classical inheritance patterns, where a single mutated gene is enough to cause disease. These are rare individually but collectively account for a meaningful share of unexplained white matter abnormalities, especially in younger patients.
CADASIL and Related Small-Vessel Diseases
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common hereditary cause of stroke in young adults. It is caused by mutations in the NOTCH3 gene and follows an autosomal dominant pattern, meaning you only need one copy of the mutated gene to develop the disease. White matter hyperintensities and small cystic lesions on MRI are its hallmark.4Neurology. Altered white and gray matter metabolism in CADASIL The mutant NOTCH3 protein causes degeneration of the smooth muscle cells lining small brain arteries, leading to recurrent small strokes.5PubMed. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain
A related condition involves mutations in the HTRA1 gene. Originally, only the recessive form (called CARASIL) was recognized, but evidence now shows that heterozygous HTRA1 mutations can also cause cerebral small-vessel disease in an autosomal dominant pattern. Compared with the classic recessive form, the dominant version tends to appear later in life and progresses more slowly.6PubMed Central. HTRA1-related autosomal dominant cerebral small vessel disease In both CADASIL and HTRA1-related disease, vascular damage in the brain tends to be more rapid and aggressive than what you see in ordinary age-related small-vessel disease.7PubMed Central. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain
Leukodystrophies
Leukodystrophies are a group of inherited disorders that specifically target white matter. They disrupt the myelin sheath, the fatty insulation around nerve fibers that allows electrical signals to travel quickly through the brain. Several distinct genetic mechanisms can cause leukodystrophies.
Metachromatic leukodystrophy (MLD) is an autosomal recessive condition, meaning a child needs to inherit a defective copy of the ARSA gene from each parent. The missing enzyme leads to a buildup of fatty substances called sulfatides, which progressively destroy myelin in both the brain and the peripheral nervous system.8Molecular Genetics and Metabolism. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype?9PubMed Central. Identification of a novel mutation in ARSA gene in three patients of an Iranian family with metachromatic leukodystrophy disorder
X-linked adrenoleukodystrophy (X-ALD) follows a different inheritance pattern. Because the ABCD1 gene sits on the X chromosome, the disease primarily affects boys and men, though female carriers can develop milder symptoms. The defective gene encodes a transporter protein in the membranes of cellular structures called peroxisomes, and without it, very long-chain fatty acids accumulate and damage myelin.10PubMed Central. Biochemical aspects of X-linked adrenoleukodystrophy11Communications Biology. Genetic analysis of the X-linked adrenoleukodystrophy gene ABCD1 in Drosophila uncovers a conserved phenotype
Vanishing white matter disease provides yet another example. Mutations in any of the five genes encoding subunits of a protein complex called eIF2B can cause this condition, where white matter progressively disappears. What makes it unusual is that episodes of deterioration are often triggered by physical trauma, fever, or other stresses. Patient cells become trapped in a prolonged state where protein production is suppressed and cannot recover normally after stress.12PubMed Central. EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response The discovery of the first genes linked to this disease was aided by founder effects in the Dutch population, where certain mutations were disproportionately common because of shared ancestry.13PubMed. Vanishing white matter disease: a review with focus on its genetics
The Polygenic Picture in Common White Matter Changes
For the vast majority of people whose MRI shows white matter hyperintensities, no single gene is responsible. Instead, large genome-wide studies have identified growing numbers of common genetic variants that each nudge risk by a small amount. A multiethnic genome-wide association study confirmed a known region on chromosome 17 and identified novel associations on chromosomes 10, 2, and 1.14PubMed Central. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI A meta-analysis in stroke patients found additional loci near genes involved in blood-vessel structure, including one near COL4A2, a collagen gene already implicated in hereditary small-vessel disease.15PubMed Central. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke
More recent work has pushed the count further. A study examining white matter hyperintensities alongside cortical thinning identified 20 genome-wide significant loci and found that the relevant genes were enriched in vascular cell types, astrocytes, and oligodendrocytes, the very cells responsible for building and maintaining myelin.16Nature Communications. Genetic risk factors underlying white matter hyperintensities and cortical atrophy This suggests that genetic susceptibility to common white matter disease doesn’t just work through blood vessels. Some variants appear to weaken the brain’s support cells directly.
When Genes and Blood Pressure Collide
One of the more clinically useful findings in this field is that genetics and lifestyle risks don’t simply add up. They interact. People who carry at least one copy of the ApoE ε4 allele (the same variant linked to Alzheimer’s risk) and also have high blood pressure develop the worst white matter lesion burden. The combination is worse than you’d predict from either risk factor alone, and the interaction was statistically significant for subcortical white matter lesions.17PubMed. Interaction between hypertension, apoE, and cerebral white matter lesions
A separate study found that among people who had suffered a stroke, the proportion of white matter hyperintensity volume attributable to common genetic variants was dramatically higher in those with hypertension (about 45% of the variance) compared with those without hypertension, where the genetic contribution was much lower and not statistically significant.18PubMed Central. Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke In plain terms, your genetic vulnerability to white matter damage matters most when your blood vessels are already under strain. If you have a family history of extensive white matter changes, controlling blood pressure is likely one of the most effective things you can do.
Multiple Sclerosis and Inherited Risk
Multiple sclerosis causes white matter lesions through a fundamentally different mechanism from vascular disease. The immune system attacks myelin, producing the characteristic plaques visible on MRI. While MS is not inherited in a straightforward way, genetics contributes meaningfully to risk.
The strongest genetic risk factor is a variant in the HLA-DRB1 gene, which increases MS risk roughly threefold. This gene encodes a protein that helps immune cells recognize and present foreign molecules, and the risk variant appears to make the immune system more likely to mistakenly target myelin.19Frontiers in Immunology. The Multiple Sclerosis (MS) Genetic Risk Factors Indicate both Acquired and Innate Immune Cell Subsets Contribute to MS Pathogenesis and Identify Novel Therapeutic Opportunities Beyond HLA-DRB1, interactions between multiple class II immune-system gene variants further modify risk.20Nature Genetics. Class II HLA interactions modulate genetic risk for multiple sclerosis For years, efforts to find robust genetic associations outside the immune-system gene region came up short, though larger studies have since identified over 200 additional risk variants, each with small individual effects.21PubMed Central. Genetics of Multiple Sclerosis: An Overview and New Directions
The practical takeaway is that having a first-degree relative with MS raises your risk, but the vast majority of relatives never develop the disease. MS involves a genetic predisposition that requires additional triggers, likely including infections and vitamin D status, to actually manifest.
Mitochondrial White Matter Disease
Mitochondrial disorders represent yet another route to hereditary white matter damage. Mitochondria have their own small genome, inherited exclusively from the mother, and mutations in mitochondrial DNA can impair energy production in ways that are particularly damaging to the brain’s energy-hungry white matter.
White matter involvement is a recognized feature of several classical mitochondrial syndromes, including Leigh disease, Kearns-Sayre syndrome, and MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes).22PubMed. White matter involvement in mitochondrial diseases Quantitative MRI research has shown that mitochondrial disease is associated with early and progressive accumulation of white matter lesions that exceeds what conventional vascular risk factors would explain. The m.3243A>G variant, one of the most common mitochondrial mutations, is particularly associated with greater white matter damage, and women carrying this variant tend to be more severely affected than men.23PubMed Central. Progressive White Matter Changes in Mitochondrial Disease: A Quantitative MRI Study
Nuclear genes that help mitochondria function can also cause white matter disease when mutated. A study of children with mitochondrial leukoencephalopathies identified variants in several nuclear-encoded genes, including NDUFV1 and NDUFS2, which encode components of the mitochondrial energy-production chain.24Multiple Sclerosis and Related Disorders. Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children? These nuclear mutations follow standard recessive or dominant inheritance patterns rather than maternal-only transmission, which means mitochondrial white matter disease can be inherited from either parent.
Family History of Dementia and White Matter Changes
Even when no specific gene has been identified, a family history of dementia appears to predict more white matter damage. People whose parents had dementia show greater white matter hyperintensity volume on brain imaging than those without such family history, and maternal history seems to carry a particularly strong association.25PubMed Central. Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease A separate study linked parental history of dementia to lower brain blood flow and a higher burden of both white matter lesions and tiny brain bleeds called microbleeds.26PubMed. Parental family history of dementia in relation to subclinical brain disease and dementia risk
Imaging research has also found that people with a parental history of Alzheimer’s disease have lower white matter integrity in brain regions known to be affected by the disease, including the cingulum, corpus callosum, and areas near the hippocampus. Carrying the ApoE ε4 allele on top of a positive family history was associated with the worst white matter integrity of any group.27PubMed Central. White matter is altered with parental family history of Alzheimer’s disease These findings suggest that some of the unexplained hereditary component of dementia may operate through damage to the brain’s wiring rather than through the amyloid plaques that get the most attention.
What Genetic Testing Can and Cannot Reveal
For people with unexplained white matter abnormalities, genetic testing has become increasingly powerful. Whole exome sequencing, which reads the protein-coding portions of nearly all genes at once, has transformed the diagnostic landscape. In one cohort of patients with unresolved white matter abnormalities, exome sequencing identified definitive disease-causing variants in about 35% of cases and likely pathogenic variants in an additional 7%, for a total diagnostic yield of about 42%.28PubMed Central. Whole exome sequencing in patients with white matter abnormalities Another study using exome sequencing in a large cohort of patients with suspected leukodystrophy reported identifying a genetic cause in about 90% of cases.29PubMed Central. Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants
The gap between those numbers is instructive. When clinicians strongly suspect a leukodystrophy based on the MRI pattern and clinical features, genetic testing confirms it most of the time. When white matter abnormalities are more ambiguous, only about four in ten yield a clear genetic diagnosis. That still represents a major improvement over the era when many of these patients went undiagnosed entirely, but it also means that a negative genetic test does not rule out a hereditary component. More than 100 heritable disorders can produce abnormal white matter on brain imaging, and new genetic causes continue to be identified.30PubMed Central. Genetic Leukoencephalopathies in Adults
Adults deserve particular attention here. White matter disease caused by genetic mutations is often thought of as a pediatric problem, but many heritable white matter disorders can first appear in adulthood. Clinicians need to consider a possible genetic cause when white matter changes look unusual for a patient’s age or don’t match the typical pattern of vascular disease, even in middle-aged and older adults.
Epigenetic Clocks and White Matter
Beyond the DNA sequence itself, newer research is exploring whether epigenetic changes, chemical modifications that affect how genes are read without altering the underlying code, predict white matter deterioration. A study examining “epigenetic age” from blood samples found that accelerated biological aging, as measured by second-generation epigenetic clocks, was strongly associated with greater white matter disease burden as well as cortical thinning in brain regions vulnerable to Alzheimer’s disease.31NPJ Dementia. DNA methylation age from peripheral blood predicts progression to Alzheimer’s disease, white matter disease burden, and cortical atrophy This line of research is still young, but it raises the possibility that a simple blood test could one day flag people whose white matter is aging faster than expected, potentially opening a window for earlier intervention.
Gene Therapy for Hereditary White Matter Diseases
For the single-gene leukodystrophies, gene therapy has moved from theory to clinical reality. The approach that has progressed furthest involves removing a patient’s own blood-forming stem cells, using a viral vector to insert a working copy of the defective gene, and then reinfusing the corrected cells. This strategy has been tested in clinical trials for X-ALD and MLD, and long-term follow-up has shown that it can halt the devastating brain deterioration caused by X-ALD.32Human Molecular Genetics. Gene therapy for leukodystrophies
In an early MLD trial, researchers transferred a functional ARSA gene into stem cells from three presymptomatic children. After reinfusion, the corrected gene was stably expressed across blood cell types and the enzyme was detectable in cerebrospinal fluid, suggesting it was reaching the brain.33PubMed. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy Current clinical trials are exploring multiple delivery methods, including direct injection of viral vectors into the brain and antisense oligonucleotides delivered into the spinal fluid.34PubMed Central. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials
The timing of treatment is critical. Gene therapy for leukodystrophies works best when given before symptoms appear or very early in the disease course. This creates an urgent practical question for families with known mutations: newborn screening and early genetic testing can identify affected children while intervention is still possible, but treatment options narrow dramatically once symptoms are advanced. For families carrying leukodystrophy mutations, genetic counseling before or during pregnancy is often the most consequential medical decision they will face.